KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Andersons (ANDE) Asset Writedowns and Impairment (2016 - 2024)

Andersons' Asset Writedowns and Impairment history spans 16 years, with the latest figure at -$69.6 million for Q4 2024.

  • For Q4 2024, Asset Writedowns and Impairment changed N/A year-over-year to -$69.6 million; the TTM value through Dec 2024 reached $17.6 million, down 79.77%, while the annual FY2025 figure was $4.7 million, 73.56% down from the prior year.
  • Asset Writedowns and Impairment for Q4 2024 was -$69.6 million at Andersons, down from $87.2 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $87.2 million in Q1 2023 and bottomed at -$69.6 million in Q4 2024.
  • The 5-year median for Asset Writedowns and Impairment is $1.1 million (2022), against an average of $9.1 million.
  • The largest annual shift saw Asset Writedowns and Impairment plummeted 752.52% in 2020 before it soared 6848.21% in 2023.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at -$8.0 million in 2020, then skyrocketed by 238.27% to $11.1 million in 2021, then tumbled by 91.26% to $973000.0 in 2022, then skyrocketed by 8861.97% to $87.2 million in 2023, then plummeted by 179.77% to -$69.6 million in 2024.
  • Per Business Quant, the three most recent readings for ANDE's Asset Writedowns and Impairment are -$69.6 million (Q4 2024), $87.2 million (Q1 2024), and $87.2 million (Q1 2023).